PKRxiv: A Best Practice Model for Advancing Pharmacoequity Through Open Pharmacokinetic Data Sharing
Clinical Pharmacology & Therapeutics · 2026
DOI: 10.1002/cpt.70206 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, 2026. Verfasst von Shakir Atoyebi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK. Hauptthemen laut MEDLINE: Information Dissemination, Pharmacokinetics, Drug Development. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Model‐informed drug development is increasingly integrated across the drug development continuum, enabling more efficient, cost‐effective, and targeted trials while reducing reliance on animal studies. Achieving pharmacoequity requires not only equitable access to medicines but also to the data and knowledge that inform drug development and regulatory decisions. To address challenges in pharmacokinetic data sharing, PKRxiv ( https://pkrxiv.org/ ) was developed as a discipline‐specific repository designed around Findable, Accessible, Interoperable, Reusable (FAIR) principles. This tutorial introduces PKRxiv’s rationale, design, data submission and access workflows, and practical use cases. Available datasets at the end of September 2025 include over 5,500 individual drug concentration‐time data points from over 900 unique participants across 3 continents. The platform supports structured submission of pharmacokinetic, pharmacogenetic, and safety/efficacy data, with persistent digital object identifiers for discoverability and citation. Contributors can apply one of three data sharing models—unrestricted, noncommercial, or contributor‐controlled—with optional embargo periods. Users can explore datasets using the Data Explorer or Data Cards, or submit requests after providing a statement of intended use case. It enables pooling of datasets across multiple studies. Recommendations to help advance the field are proposed as data sharing becomes more widely expected: obtaining consent for unspecified future research use of data, sharing data underlying peer‐reviewed publications as standard practice, including discipline‐specific repositories in data management plans, and incentivizing post‐approval data sharing by industry. Supporting data from all therapeutic areas and population groups, PKRxiv is a critical step toward a more transparent, equitable, and collaborative future in clinical pharmacology research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
- Centre of Excellence for Long-acting Therapeutics, University of Liverpool, Liverpool, UK.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Obafemi Awolowo University, Ile Ife, Nigeria.
- UniSA Clinical and Health Sciences, Health and Biomedical Innovation, University of South Australia, Adelaide, South Australia, Australia.
- Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmaceutical Sciences, University of Ilorin, Ilorin, Nigeria.
- Department of Pharmacy Practice and Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California, USA.
ORCID-Profile: Shakir Atoyebi, Prajith Venkatasubramanian, Abdulafeez Akinloye, Oluwasegun Eniayewu, Brookie M Best, Laura Else, Adeniyi Olagunju
Zitieren
APA
Atoyebi, S., Venkatasubramanian, P., Akinloye, A., Eniayewu, O., Best, B. M., Else, L., & Olagunju, A. (2026). PKRxiv: A Best Practice Model for Advancing Pharmacoequity Through Open Pharmacokinetic Data Sharing. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70206
Vancouver
Atoyebi S, Venkatasubramanian P, Akinloye A, Eniayewu O, Best BM, Else L, et al. PKRxiv: A Best Practice Model for Advancing Pharmacoequity Through Open Pharmacokinetic Data Sharing. Clinical Pharmacology & Therapeutics. 2026. doi:10.1002/cpt.70206
BibTeX
@article{Atoyebi2026,
author = {Atoyebi, Shakir and Venkatasubramanian, Prajith and Akinloye, Abdulafeez and Eniayewu, Oluwasegun and Best, Brookie M and Else, Laura and Olagunju, Adeniyi},
title = {PKRxiv: A Best Practice Model for Advancing Pharmacoequity Through Open Pharmacokinetic Data Sharing},
journal = {Clinical Pharmacology & Therapeutics},
year = {2026},
doi = {10.1002/cpt.70206}
}
EUVIMED